What does FDA advise consumers to do if they are taking medicines from Caraco?
The FDA advises consumers taking medicines from Caraco not to interrupt their drug therapy. If FDA identifies Caraco drugs on the market that pose risks to patient safety, the Agency will take additional regulatory action and immediately notify the public. Maintaining drug quality standards remains a top priority for FDA. Should I see my health care provider if I want my prescription refilled with a drug from a manufacturer other than Caraco? FDA advises any consumer who is concerned about their drugs to discuss those concerns with their health care providers. Where can I find additional information on the current Good Manufacturing Practices (cGMPs) and how these practices contribute to drug quality? FDA has recently posted additional information on cGMP. That information can be found at http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Manufacturing/ucm169105.htm. This post discusses the role and importance of cGMP in drug manufacturing, as well as describes what actions FDA takes
